Asensus Surgical (ASXC) Reports Prelim Q4 Revenue of $2.2M-$2.8M

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/1/2026

1. SPY
2. MDT
3. ENOV
4. AON
5. AZN
6. BLSM
7. GPRO
8. GRMN
9. KRMN
10. VRSK

Go back to Asensus Surgical (ASXC) Reports Prelim Q4 Revenue of $2.2M-$2.8M

Asensus Surgical Provides Preliminary 2022 Year-End Corporate Update

January 9, 2023 6:55 AM EST

RESEARCH TRIANGLE PARK, N.C., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery, today provided a preliminary 2022 year-end corporate update.

Fourth Quarter Highlights

Over 690 procedures were performed globally during the quarter, representing growth of over 23% compared to the fourth quarter 2021Five Senhance® Surgical Programs were initiated during the quarter, including two in Germany, two in Japan, and one in the CIS regionFourth... More